A detailed history of V2 Financial Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, V2 Financial Group LLC holds 4,500 shares of BMY stock, worth $249,525. This represents 0.15% of its overall portfolio holdings.

Number of Shares
4,500
Holding current value
$249,525
% of portfolio
0.15%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$40.25 - $52.99 $181,125 - $238,455
4,500 New
4,500 $220 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $118B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track V2 Financial Group LLC Portfolio

Follow V2 Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of V2 Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on V2 Financial Group LLC with notifications on news.